Sold 1,451 shares
of Common Stock
at $92.34 per share
(Direct)
Date: 2026-08-22 |
Code: F
| equity_swap_involved: 0 | shares_owned_after: 128,608.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
F1: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.
F2: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027.
🔍 Stern Sadie (Executive)
Company: DEXCOM INC (DXCM)
Report Date: 2026-08-22
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-08-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 128,608.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes: